Obolenskoe FP Neobutin tablets 100mg # 10

Structure

1 tablet contains:

active substance: trimebutine maleate 100 mg

excipients: lactose monohydrate 81.6 mg, corn starch 32 mg, colloidal silicon dioxide (aerosil) 3.2 mg, magnesium stearate 3.2 mg.

pharmachologic effect

Antispasmodic

Indications

- irritable bowel syndrome

- postoperative paralytic intestinal obstruction.

Contraindications

- children's age up to 3 years (for this dosage form)

- pregnancy

- lactose intolerance, lactase deficiency, glucose-galactose malabsorption

- hypersensitivity to trimebutin maleate and other components that make up the drug.

Side effects

From the digestive system: dry mouth, unpleasant taste, diarrhea, dyspepsia, nausea, constipation.

From the nervous system: drowsiness, fatigue, dizziness, headache, anxiety, feeling of heat or cold.

Allergic reactions: skin rash.

Others: menstrual irregularities, painful enlargement of the mammary glands, urinary retention.

Interaction

Drug interaction of the drug Neobutin is not described.

How to take, course of administration and dosage

The drug is taken orally, before meals.

Adults and children over 12 years of age are prescribed 100-200 mg 3 times / day.

To prevent recurrence of irritable bowel syndrome after the course of treatment during the period of remission, it is recommended to continue taking the drug at a dose of 300 mg / day for 12 weeks.

Children aged 5-12 years are prescribed 50 mg 3 times / day, children aged 3-5 years - 25 mg 3 times / day.

Overdose

To date, no cases of trimebutine overdose have been reported.

Special instructions

The course of treatment of irritable bowel syndrome in the acute period at a dose of 600 mg / day for 4 weeks and the continuation of treatment after the course of the course at a dose of 300 mg / day for 12 weeks avoids the recurrence of the disease.

Influence on the ability to drive vehicles and use mechanisms

The drug does not have a sedative effect, does not affect the speed of psychomotor reactions and can be used in people of various professions, incl.

requiring increased attention and coordination of movements.

However, given the possible side effects that can affect these abilities (dizziness and others), care should be taken when driving and engaging in other potentially hazardous activities.

Active substance

Trimebutin

Name ENG

NEOBUTIN

Clinical and pharmacological group

A drug that regulates the motor function of the gastrointestinal tract

ATX code

Trimebutine

Dosage

100mg

Structure

1 tablet contains: active ingredient: trimebutine maleate 100 mg excipients: lactose monohydrate 81.6 mg, corn starch 32 mg, colloidal silicon dioxide (aerosil) 3.2 mg, magnesium stearate 3.2 mg.

Indications

Irritable bowel syndrome postoperative paralytic ileus

Contraindications

children under 3 years of age (for this dosage form)

pregnancy

lactose intolerance, lactase deficiency, glucose-galactose malabsorption

hypersensitivity to trimebutin maleate and other components that make up the drug.

INN / Active ingredient

Trimebutin

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

ten

Scope of application

Gastroenterology

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Obolenskoe FP

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antispasmodic

Anatomical and therapeutic characteristics

A03AA05 Trimebutin

Dosage form

Pills

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

1 tablet contains: trimebutin maleate 100 mg

The target audience

Adult

Package weight, g

twenty

Mode of application

:

The drug is taken orally, before meals. < br> Adults and children over 12 years of age are prescribed 100-200 mg 3 times / day. < br> To prevent recurrence of irritable bowel syndrome after the course of treatment during the period of remission, it is recommended to continue taking the drug in the dose 300 mg / day for 12 weeks. < br> Children aged 5-12 years are prescribed 50 mg 3 times / day, children aged 3-5 years - 25 mg 3 times / day. < br>